Pierre P. Massion

What is he best known for?

The fields of study he is best known for:

• Cancer
• Gene
• Internal medicine

His main research concerns Lung cancer, Cancer research, Pathology, Cancer and Lung. His research integrates issues of Carcinogenesis and Cohort in his study of Lung cancer. His Cancer research study incorporates themes from Mutation, Gene mutation, Signal transduction, Exon and Rovalpituzumab tesirine.

His Pathology study integrates concerns from other disciplines, such as Biomarker, Proteomics and Adenocarcinoma. His Cancer research incorporates elements of Survival rate, Carcinoma, Immunology and Hazard ratio. His Lung research is multidisciplinary, incorporating elements of Frozen section procedure and Receiver operating characteristic.

His most cited work include:

• ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers (1094 citations)
• Comprehensive genomic profiles of small cell lung cancer (866 citations)
• The national lung screening trial: Overview and study design (715 citations)

What are the main themes of his work throughout his whole career to date?

Pierre P. Massion mostly deals with Lung cancer, Cancer research, Internal medicine, Cancer and Pathology. His research in Lung cancer intersects with topics in Biomarker, Radiology, Lung and Early detection. His research integrates issues of Non small cell, Small Cell Lung Carcinoma, Cell growth, Metastasis and Adenocarcinoma in his study of Cancer research.

Pierre P. Massion has included themes like Gastroenterology, Endocrinology and Oncology in his Internal medicine study. His research investigates the connection with Cancer and areas like Immunology which intersect with concerns in COPD. His research in Pathology tackles topics such as Proteomics which are related to areas like Bioinformatics.

He most often published in these fields:

• Lung cancer (76.56%)
• Cancer research (30.99%)
• Internal medicine (27.60%)

What were the highlights of his more recent work (between 2018-2021)?

• Lung cancer (76.56%)
• Cancer research (30.99%)
• Lung (25.26%)

In recent papers he was focusing on the following fields of study:

Lung cancer, Cancer research, Lung, Internal medicine and Lung cancer screening are his primary areas of study. His work carried out in the field of Lung cancer brings together such families of science as Retrospective cohort study, Emergency medicine, Confidence interval, Radiology and Tumor progression. The concepts of his Cancer research study are interwoven with issues in Cell growth, Autoantibody, Small hairpin RNA, Non small cell and Adenocarcinoma.

In his research on the topic of Lung, Computed tomographic, Prostate, Noninvasive biomarkers and Diagnostic biomarker is strongly related with Nodule. His Internal medicine study combines topics in areas such as Gastroenterology and Oncology. Pierre P. Massion studied Cohort and Cancer that intersect with CD8.

Between 2018 and 2021, his most popular works were:

• Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. (169 citations)
• Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges (77 citations)
• The Human Tumor Atlas Network: Charting Tumor Transitions Across Space and Time at Single-Cell Resolution (65 citations)

In his most recent research, the most cited papers focused on:

• Cancer
• Gene
• Internal medicine

His scientific interests lie mostly in Lung cancer, Lung, Internal medicine, Cancer research and Lung cancer screening. His Lung cancer study incorporates themes from Retrospective cohort study, Confidence interval, Tumor progression, Qualitative feedback and Receiver operating characteristic. His Lung research is multidisciplinary, incorporating perspectives in Normal results, Curative treatment and Emergency medicine.

Pierre P. Massion works mostly in the field of Internal medicine, limiting it down to topics relating to Oncology and, in certain cases, Human genetics and Non invasive. His Cancer research research includes elements of Cell growth, NEUROD1, ASCL1, Small hairpin RNA and Genetically Engineered Mouse. The various areas that Pierre P. Massion examines in his Lung cancer screening study include Odds ratio, Guideline and Family medicine.